Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 739

1.

Photooxidation Reactions of Cyclometalated Palladium(II) and Platinum(II) Complexes.

Yasuda J, Inoue K, Mizuno K, Arai S, Uehara K, Kikuchi A, Yan YN, Yamanishi K, Kataoka Y, Kato M, Kawai A, Kawamoto T.

Inorg Chem. 2019 Nov 13. doi: 10.1021/acs.inorgchem.9b01492. [Epub ahead of print]

PMID:
31718162
2.

Expanding the clinicopathologic and molecular spectrum of BCOR-associated sarcomas in adults.

Yoshida A, Arai Y, Hama N, Chikuta H, Bando Y, Nakano S, Kobayashi E, Shibahara J, Fukuhara H, Komiyama M, Watanabe SI, Tamura K, Kawai A, Shibata T.

Histopathology. 2019 Oct 24. doi: 10.1111/his.14023. [Epub ahead of print]

PMID:
31647130
3.

Establishment and characterization of novel patient-derived extraskeletal osteosarcoma cell line NCC-ESOS1-C1.

Kito F, Oyama R, Noguchi R, Hattori E, Sakumoto M, Endo M, Kobayashi E, Yoshida A, Kawai A, Kondo T.

Hum Cell. 2019 Oct 17. doi: 10.1007/s13577-019-00291-z. [Epub ahead of print]

PMID:
31625124
4.

Immune correlates of the differing pathological and therapeutic effects of neoadjuvant chemotherapy in breast cancer.

Kim R, Kawai A, Wakisaka M, Sawada S, Shimoyama M, Yasuda N, Hidaka M, Morita Y, Ohtani S, Arihiro K.

Eur J Surg Oncol. 2019 Sep 18. pii: S0748-7983(19)30812-1. doi: 10.1016/j.ejso.2019.09.146. [Epub ahead of print]

PMID:
31563296
5.

Complementary vibrational spectroscopy.

Hashimoto K, Badarla VR, Kawai A, Ideguchi T.

Nat Commun. 2019 Sep 27;10(1):4411. doi: 10.1038/s41467-019-12442-9.

6.

Systemic treatments in MDM2 positive intimal sarcoma: A multicentre experience with anthracycline, gemcitabine, and pazopanib within the World Sarcoma Network.

Frezza AM, Assi T, Lo Vullo S, Ben-Ami E, Dufresne A, Yonemori K, Noguchi E, Siontis B, Ferraro R, Teterycz P, Duffaud F, Ravi V, Vincenzi B, Gelderblom H, Pantaleo MA, Baldi GG, Desar I, Fedenko A, Maki RG, Jones RL, Benjamin RS, Blay JY, Kawai A, Gounder M, Gronchi A, Le Cesne A, Mir O, Czarnecka AM, Schuetze S, Wagner AJ, Adam J, Barisella M, Sbaraglia M, Hornick JL, Meurgey A, Mariani L, Casali PG, Thornton K, Stacchiotti S.

Cancer. 2019 Sep 19. doi: 10.1002/cncr.32508. [Epub ahead of print]

PMID:
31536651
7.

The Effects of Using Pancreases Obtained from Brain-Dead Donors for Clinical Islet Transplantation in Japan.

Ito T, Kenmochi T, Kurihara K, Kawai A, Aida N, Akashi Y, Kato S.

J Clin Med. 2019 Sep 10;8(9). pii: E1430. doi: 10.3390/jcm8091430.

8.

Ten-year follow-up results of perioperative chemotherapy with doxorubicin and ifosfamide for high-grade soft-tissue sarcoma of the extremities: Japan Clinical Oncology Group study JCOG0304.

Tanaka K, Mizusawa J, Naka N, Kawai A, Katagiri H, Hiruma T, Matsumoto Y, Tsuchiya H, Nakayama R, Hatano H, Emori M, Watanuki M, Yoshida Y, Okamoto T, Abe S, Asanuma K, Yokoyama R, Hiraga H, Yonemoto T, Morii T, Ae K, Nagano A, Yoshikawa H, Fukuda H, Ozaki T, Iwamoto Y.

BMC Cancer. 2019 Sep 6;19(1):890. doi: 10.1186/s12885-019-6114-2.

9.

The Outcomes of Pancreatic Transplantation from Pediatric Donors-A Single Institution Experience.

Ito T, Kenmochi T, Aida N, Kurihara K, Kawai A, Suzuki A, Shibata M, Hiratsuka I, Hasegawa M.

J Clin Med. 2019 Sep 4;8(9). pii: E1386. doi: 10.3390/jcm8091386.

10.

Species-Specific Quantitative Proteomics Profiles of Sarcoma Patient-Derived Models Closely Reflect Their Primary Tumors.

Shiozawa K, Oyama R, Takahashi M, Kito F, Hattori E, Yoshida A, Kawai A, Ono M, Kondo T.

Proteomics Clin Appl. 2019 Aug 16:e1900054. doi: 10.1002/prca.201900054. [Epub ahead of print]

PMID:
31419061
11.

Selective inhibition of mutant IDH1 by DS-1001b ameliorates aberrant histone modifications and impairs tumor activity in chondrosarcoma.

Nakagawa M, Nakatani F, Matsunaga H, Seki T, Endo M, Ogawara Y, Machida Y, Katsumoto T, Yamagata K, Hattori A, Fujita S, Aikawa Y, Ishikawa T, Soga T, Kawai A, Chuman H, Yokoyama N, Fukushima S, Yahiro K, Kimura A, Shimada E, Hirose T, Fujiwara T, Setsu N, Matsumoto Y, Iwamoto Y, Nakashima Y, Kitabayashi I.

Oncogene. 2019 Oct;38(42):6835-6849. doi: 10.1038/s41388-019-0929-9. Epub 2019 Aug 12.

PMID:
31406254
12.

Interim results of a real-world observational study of eribulin in soft tissue sarcoma including rare subtypes.

Kobayashi E, Naito Y, Asano N, Maejima A, Endo M, Takahashi S, Megumi Y, Kawai A.

Jpn J Clin Oncol. 2019 Jul 31. pii: hyz096. doi: 10.1093/jjco/hyz096. [Epub ahead of print]

PMID:
31365116
13.

A Japanese nationwide survey on the cryopreservation of embryos, oocytes and ovarian tissue for cancer patients.

Sanada Y, Harada M, Kunitomi C, Kanatani M, Izumi G, Hirata T, Fujii T, Suzuki N, Morishige KI, Aoki D, Irahara M, Tsugawa K, Tanimoto M, Nishiyama H, Hosoi H, Sugiyama K, Kawai A, Osuga Y.

J Obstet Gynaecol Res. 2019 Oct;45(10):2021-2028. doi: 10.1111/jog.14073. Epub 2019 Jul 30.

PMID:
31364239
14.

Incidence of Skeletal-Related Events in Patients with Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the US.

Kawai AT, Martinez D, Saltus CW, Vassilev ZP, Soriano-Gabarró M, Kaye JA.

Prostate Cancer. 2019 Jul 9;2019:5971615. doi: 10.1155/2019/5971615. eCollection 2019.

15.

Clinical features and treatment outcome of desmoid-type fibromatosis: based on a bone and soft tissue tumor registry in Japan.

Nishida Y, Kawai A, Toguchida J, Ogose A, Ae K, Kunisada T, Matsumoto Y, Matsunobu T, Takahashi K, Nishida K, Ozaki T.

Int J Clin Oncol. 2019 Nov;24(11):1498-1505. doi: 10.1007/s10147-019-01512-z. Epub 2019 Jul 22.

PMID:
31332613
16.

Expanding the Phenotypic Spectrum of Mesenchymal Tumors Harboring the EWSR1-CREM Fusion.

Yoshida A, Wakai S, Ryo E, Miyata K, Miyazawa M, Yoshida KI, Motoi T, Ogawa C, Iwata S, Kobayashi E, Watanabe SI, Kawai A, Mori T.

Am J Surg Pathol. 2019 Dec;43(12):1622-1630. doi: 10.1097/PAS.0000000000001331.

PMID:
31305268
17.

Absence of H3F3A mutation in a subset of malignant giant cell tumor of bone.

Yoshida KI, Nakano Y, Honda-Kitahara M, Wakai S, Motoi T, Ogura K, Sano N, Shibata T, Okuma T, Iwata S, Kawai A, Ichimura K, Yoshida A.

Mod Pathol. 2019 Jul 8. doi: 10.1038/s41379-019-0318-5. [Epub ahead of print]

PMID:
31285528
18.

Development of nomograms for prognostication of patients with primary soft tissue sarcomas of the trunk and extremity: report from the Bone and Soft Tissue Tumor Registry in Japan.

Sekimizu M, Ogura K, Yasunaga H, Matsui H, Tanaka S, Inagaki K, Kawai A.

BMC Cancer. 2019 Jul 4;19(1):657. doi: 10.1186/s12885-019-5875-y.

19.

Evaluation of Q Gene Mycobacteria: A novel and easy nucleic acid chromatography method for mycobacterial species identification.

Chikamatsu K, Aono A, Kawai A, Hata H, Iwamoto T, Igarashi Y, Takaki A, Yamada H, Mitarai S.

J Microbiol Methods. 2019 Aug;163:105657. doi: 10.1016/j.mimet.2019.105657. Epub 2019 Jun 19.

PMID:
31228476
20.

Validation of febrile seizures identified in the Sentinel Post-Licensure Rapid Immunization Safety Monitoring Program.

Kawai AT, Martin D, Henrickson SE, Goff A, Reidy M, Santiago D, Selvam N, Selvan M, McMahill-Walraven C, Lee GM.

Vaccine. 2019 Jul 9;37(30):4172-4176. doi: 10.1016/j.vaccine.2019.05.042. Epub 2019 Jun 8.

PMID:
31186192
21.

Osteosarcoma in patients over 50 years of age: Multi-institutional retrospective analysis of 104 patients.

Nagano A, Matsumoto S, Kawai A, Okuma T, Hiraga H, Matsumoto Y, Nishida Y, Yonemoto T, Hosaka M, Takahashi M, Yoshikawa H, Kunisada T, Asanuma K, Naka N, Emori M, Kubo T, Kawashima H, Kawamoto T, Yokoyama R, Tsukushi S, Sato K, Okamoto T, Hiraoka K, Morioka H, Tanaka K, Takagi T, Iwamoto Y, Ozaki T.

J Orthop Sci. 2019 May 30. pii: S0949-2658(19)30128-9. doi: 10.1016/j.jos.2019.04.008. [Epub ahead of print]

PMID:
31155441
22.

A clinical comparison between dedifferentiated low-grade osteosarcoma and conventional osteosarcoma.

Toki S, Kobayashi E, Yoshida A, Ogura K, Wakai S, Yoshimoto S, Yonemori K, Kawai A.

Bone Joint J. 2019 Jun;101-B(6):745-752. doi: 10.1302/0301-620X.101B6.BJJ-2018-1207.R1.

PMID:
31154837
23.

Determination of iris thickness development in children using swept-source anterior-segment optical coherence tomography.

Nakakura S, Nagata Y, Shimizu Y, Kawai A, Tabuchi H, Kiuchi Y.

PLoS One. 2019 May 28;14(5):e0217656. doi: 10.1371/journal.pone.0217656. eCollection 2019.

24.

KMT2A (MLL) fusions in aggressive sarcomas in young adults.

Yoshida A, Arai Y, Tanzawa Y, Wakai S, Hama N, Kawai A, Shibata T.

Histopathology. 2019 Oct;75(4):508-516. doi: 10.1111/his.13926. Epub 2019 Aug 8.

PMID:
31136005
25.

PML-RARα induces all-trans retinoic acid-dependent transcriptional activation through interaction with MED1.

Fukuoka T, Kawai A, Takahara T, Mori M, Roeder RG, Hasegawa N, Ito M.

Transcription. 2019 Jun;10(3):147-156. doi: 10.1080/21541264.2019.1624467. Epub 2019 Jun 5.

PMID:
31135261
26.

Massively parallel sequencing of tenosynovial giant cell tumors reveals novel CSF1 fusion transcripts and novel somatic CBL mutations.

Tsuda Y, Hirata M, Katayama K, Motoi T, Matsubara D, Oda Y, Fujita M, Kobayashi H, Kawano H, Nishida Y, Sakai T, Okuma T, Goto T, Ogura K, Kawai A, Ae K, Anazawa U, Suehara Y, Iwata S, Miyano S, Imoto S, Shibata T, Nakagawa H, Yamaguchi R, Tanaka S, Matsuda K.

Int J Cancer. 2019 Dec 15;145(12):3276-3284. doi: 10.1002/ijc.32421. Epub 2019 May 31.

PMID:
31107544
27.

Low-grade endometrial stromal sarcoma with a novel MEAF6-SUZ12 fusion.

Makise N, Sekimizu M, Kobayashi E, Yoshida H, Fukayama M, Kato T, Kawai A, Ichikawa H, Yoshida A.

Virchows Arch. 2019 Oct;475(4):527-531. doi: 10.1007/s00428-019-02588-8. Epub 2019 May 17.

PMID:
31101969
28.

Minimal clinically important differences in Toronto Extremity Salvage Score for patients with lower extremity sarcoma.

Ogura K, Uehara K, Akiyama T, Shinoda Y, Iwata S, Tsukushi S, Kobayashi E, Hirose T, Yonemoto T, Endo M, Tanzawa Y, Nakatani F, Kawano H, Tanaka S, Kawai A.

J Orthop Sci. 2019 Apr 16. pii: S0949-2658(19)30118-6. doi: 10.1016/j.jos.2019.03.022. [Epub ahead of print]

PMID:
31000377
29.

Association between change in self-efficacy and reduction in disability among patients with chronic pain.

Karasawa Y, Yamada K, Iseki M, Yamaguchi M, Murakami Y, Tamagawa T, Kadowaki F, Hamaoka S, Ishii T, Kawai A, Shinohara H, Yamaguchi K, Inada E.

PLoS One. 2019 Apr 16;14(4):e0215404. doi: 10.1371/journal.pone.0215404. eCollection 2019.

30.

Calreticulin as A Novel Potential Metastasis-Associated Protein in Myxoid Liposarcoma, as Revealed by Two-Dimensional Difference Gel Electrophoresis.

Tajima T, Kito F, Yoshida A, Kawai A, Kondo T.

Proteomes. 2019 Apr 10;7(2). pii: E13. doi: 10.3390/proteomes7020013.

31.

[Ⅰ.New TNM Classification of Bone and Soft Tissue Sarcoma-Changes between the 7th and 8th Editions].

Mori T, Kobayashi E, Kawai A.

Gan To Kagaku Ryoho. 2019 Mar;46(3):433-436. Japanese. No abstract available.

PMID:
30914579
32.

[Musculoskeletal Tumor Recent Topics in Musculoskeletal Tumors(Sarcomas)].

Kawai A.

Gan To Kagaku Ryoho. 2019 Mar;46(3):432. Japanese. No abstract available.

PMID:
30914578
33.

A serum microRNA classifier for the diagnosis of sarcomas of various histological subtypes.

Asano N, Matsuzaki J, Ichikawa M, Kawauchi J, Takizawa S, Aoki Y, Sakamoto H, Yoshida A, Kobayashi E, Tanzawa Y, Nakayama R, Morioka H, Matsumoto M, Nakamura M, Kondo T, Kato K, Tsuchiya N, Kawai A, Ochiya T.

Nat Commun. 2019 Mar 21;10(1):1299. doi: 10.1038/s41467-019-09143-8.

34.

A randomized phase III trial of denosumab before curettage for giant cell tumor of bone: Japan Clinical Oncology Group Study JCOG1610.

Urakawa H, Mizusawa J, Tanaka K, Eba J, Hiraga H, Kawai A, Nishida Y, Hosaka M, Iwamoto Y, Fukuda H, Ozaki T.

Jpn J Clin Oncol. 2019 Apr 1;49(4):379-382. doi: 10.1093/jjco/hyz004.

PMID:
30796832
35.

Human mass balance, pharmacokinetics and metabolism of rovatirelin and identification of its metabolic enzymes in vitro.

Kobayshi K, Abe Y, Kawai A, Furihata T, Harada H, Endo T, Takeda H.

Xenobiotica. 2019 Dec;49(12):1434-1446. doi: 10.1080/00498254.2019.1580796. Epub 2019 Mar 5.

PMID:
30747023
36.

Randomized placebo-controlled double-blind phase II study of zaltoprofen for patients with diffuse-type and unresectable localized tenosynovial giant cell tumors: a study protocol.

Takeuchi A, Nomura A, Yamamoto N, Hayashi K, Igarashi K, Tandai S, Kawai A, Matsumine A, Miwa S, Nishida Y, Nakamura T, Terauchi R, Hoshi M, Kunisada T, Endo M, Yoshimura K, Murayama T, Tsuchiya H.

BMC Musculoskelet Disord. 2019 Feb 9;20(1):68. doi: 10.1186/s12891-019-2453-z.

37.

Establishment and characterization of a novel dedifferentiated chondrosarcoma cell line, NCC-dCS1-C1.

Oyama R, Kito F, Takahashi M, Sakumoto M, Shiozawa K, Qiao Z, Noguchi R, Kubo T, Toki S, Nakatani F, Yoshida A, Kawai A, Kondo T.

Hum Cell. 2019 Apr;32(2):202-213. doi: 10.1007/s13577-018-00232-2. Epub 2019 Feb 8.

PMID:
30737713
38.

Establishment and characterization of a novel cell line, NCC-MFS1-C1, derived from a patient with myxofibrosarcoma.

Kito F, Oyama R, Sakumoto M, Shiozawa K, Qiao Z, Toki S, Yoshida A, Kawai A, Kondo T.

Hum Cell. 2019 Apr;32(2):214-222. doi: 10.1007/s13577-018-00233-1. Epub 2019 Feb 8.

PMID:
30737712
39.

A potential role for peripheral natural killer cell activity induced by preoperative chemotherapy in breast cancer patients.

Kim R, Kawai A, Wakisaka M, Funaoka Y, Yasuda N, Hidaka M, Morita Y, Ohtani S, Ito M, Arihiro K.

Cancer Immunol Immunother. 2019 Apr;68(4):577-585. doi: 10.1007/s00262-019-02305-z. Epub 2019 Jan 23.

PMID:
30673828
40.

Flap reconstruction after groin and medial thigh sarcoma resection reduces the risk of lower-extremity lymphedema.

Tashiro K, Arikawa M, Kagaya Y, Kobayashi E, Kawai A, Miyamoto S.

J Plast Reconstr Aesthet Surg. 2019 Apr;72(4):685-710. doi: 10.1016/j.bjps.2019.01.009. Epub 2019 Jan 12. No abstract available.

PMID:
30661914
41.

Analysis of mutations in primary and metastatic synovial sarcoma.

Xing Z, Wei L, Jiang X, Conroy J, Glenn S, Bshara W, Yu T, Pao A, Tanaka S, Kawai A, Choi C, Wang J, Liu S, Morrison C, Yu YE.

Oncotarget. 2018 Dec 7;9(96):36878-36888. doi: 10.18632/oncotarget.26416. eCollection 2018 Dec 7.

42.

Frequent mutations of genes encoding vacuolar H+ -ATPase components in granular cell tumors.

Sekimizu M, Yoshida A, Mitani S, Asano N, Hirata M, Kubo T, Yamazaki F, Sakamoto H, Kato M, Makise N, Mori T, Yamazaki N, Sekine S, Oda I, Watanabe SI, Hiraga H, Yonemoto T, Kawamoto T, Naka N, Funauchi Y, Nishida Y, Honoki K, Kawano H, Tsuchiya H, Kunisada T, Matsuda K, Inagaki K, Kawai A, Ichikawa H.

Genes Chromosomes Cancer. 2019 Jun;58(6):373-380. doi: 10.1002/gcc.22727. Epub 2019 Jan 21.

PMID:
30597645
43.

Effectiveness of Preceding Solo Kidney Transplantation for Type 1 Diabetes With End-Stage Renal Failure.

Ito T, Kenmochi T, Aida N, Kurihara K, Kawai A, Ito T.

Transplant Proc. 2018 Dec;50(10):3249-3254. doi: 10.1016/j.transproceed.2018.06.014. Epub 2018 Jun 22.

PMID:
30577193
44.

Novel NTRK3 Fusions in Fibrosarcomas of Adults.

Yamazaki F, Nakatani F, Asano N, Wakai S, Sekimizu M, Mitani S, Kubo T, Kawai A, Ichikawa H, Yoshida A.

Am J Surg Pathol. 2019 Apr;43(4):523-530. doi: 10.1097/PAS.0000000000001194.

PMID:
30520818
45.

Warm ischemic time as a critical risk factor of graft failure from donors after cardiac death: A single-center experience over three decades in the Kidney Donor Profile Index/Kidney Donor Risk Index era in Japan.

Kusaka M, Kubota Y, Takahashi H, Sasaki H, Kawai A, Takenaka M, Fukami N, Kenmochi T, Shiroki R, Hoshinaga K.

Int J Urol. 2019 Feb;26(2):247-252. doi: 10.1111/iju.13851. Epub 2018 Nov 20.

PMID:
30460731
46.

Development of a patient-oriented disease specific outcome measure of health-related quality of life (HRQOL) for musculoskeletal oncology patients.

Ogura K, Uehara K, Akiyama T, Shinoda Y, Iwata S, Tsukushi S, Kobayashi E, Hirose T, Yonemoto T, Endo M, Tanzawa Y, Nakatani F, Kawano H, Tanaka S, Kawai A.

J Orthop Sci. 2019 May;24(3):539-547. doi: 10.1016/j.jos.2018.10.020. Epub 2018 Nov 13.

PMID:
30446332
47.

Long-term maintenance of hemoglobin levels in hemodialysis patients treated with bi-weekly epoetin beta pegol switched from darbepoetin alfa: a single-center, 12-month observational study in Japan.

Kawai T, Kusano Y, Yamada K, Ueda C, Kawai A, Masaki T.

J Artif Organs. 2019 Jun;22(2):146-153. doi: 10.1007/s10047-018-1080-z. Epub 2018 Nov 14.

PMID:
30426250
48.

Establishment of novel patient-derived models of dermatofibrosarcoma protuberans: two cell lines, NCC-DFSP1-C1 and NCC-DFSP2-C1.

Oyama R, Kito F, Qiao Z, Sakumoto M, Shiozawa K, Toki S, Yoshida A, Kawai A, Kondo T.

In Vitro Cell Dev Biol Anim. 2019 Jan;55(1):62-73. doi: 10.1007/s11626-018-0305-z. Epub 2018 Nov 8.

PMID:
30411273
49.

Analysis of the Binding of Aripiprazole to Human Serum Albumin: The Importance of a Chloro-Group in the Chemical Structure.

Sakurama K, Kawai A, Tuan Giam Chuang V, Kanamori Y, Osa M, Taguchi K, Seo H, Maruyama T, Imoto S, Yamasaki K, Otagiri M.

ACS Omega. 2018 Oct 31;3(10):13790-13797. doi: 10.1021/acsomega.8b02057. Epub 2018 Oct 22.

50.

A Cost Effective Easy Competitive Enzyme-Linked Immunosorbent Assay Suitable for Monitoring Protective Immunity against the Rabies Virus in the Serum of Humans and Dogs.

Aronthippaitoon Y, Samer W, Atuntee T, Thananchai H, Thongkorn K, Pongsopawijit P, Inoue S, Noguchi A, Park ES, Kawai A, Petsophonsakul W.

Jpn J Infect Dis. 2019 Mar 25;72(2):99-105. doi: 10.7883/yoken.JJID.2018.248. Epub 2018 Oct 31.

Supplemental Content

Support Center